Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality

This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than amo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-03, Vol.382 (11), p.1018-1028
Hauptverfasser: Simon, Tracey G, Duberg, Ann-Sofi, Aleman, Soo, Chung, Raymond T, Chan, Andrew T, Ludvigsson, Jonas F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1028
container_issue 11
container_start_page 1018
container_title The New England journal of medicine
container_volume 382
creator Simon, Tracey G
Duberg, Ann-Sofi
Aleman, Soo
Chung, Raymond T
Chan, Andrew T
Ludvigsson, Jonas F
description This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than among nonusers.
doi_str_mv 10.1056/NEJMoa1912035
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_472822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2376284814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-da970b7fffee4ea5ad0c9fe3caf70f73b488bdf271eefba9c79d4b79becbfb73</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EokvhyBVFQtwI-Cuxc0FaLaUFbQGhiqtlO-PWSxIvttOq_75GuxT20JGsGdnPvGP7Reglwe8Ibtr3X0--nAdNOkIxax6hBWkYqznH7WO0wJjKmouOHaFnKW1wCcK7p-iIUdLitmUL9H2ZUrBeZx-mKrhqmbY--qm68fmqOoOtzsHCMMyDjtVKR-unMOpKT3219tcQ6x8w6Ax9dR5i1oPPt8_RE6eHBC_2-RhdfDq5WJ3V62-nn1fLdW2blue6153ARjjnADjoRvfYdg6Y1U5gJ5jhUpreUUEAnNGdFV3PjegMWOOMYMeo3smmG9jORm2jH3W8VUF7td_6VSpQXFBJaeHfPsh_9D-XKsTLsmYlSSNZwT_s8MKO0FuYctTDQdfhyeSv1GW4VoIR0XJZBF7vBWL4PUPKahPmOJUfUZSJlkouCf_3ChtDShHc_QSC1R971YG9hX_1_7Xu6b9-FuDNDhjHpCbYjA8I3QHyx7BK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2376284814</pqid></control><display><type>article</type><title>Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><source>New England Journal of Medicine</source><creator>Simon, Tracey G ; Duberg, Ann-Sofi ; Aleman, Soo ; Chung, Raymond T ; Chan, Andrew T ; Ludvigsson, Jonas F</creator><creatorcontrib>Simon, Tracey G ; Duberg, Ann-Sofi ; Aleman, Soo ; Chung, Raymond T ; Chan, Andrew T ; Ludvigsson, Jonas F</creatorcontrib><description>This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than among nonusers.</description><identifier>ISSN: 0028-4793</identifier><identifier>ISSN: 1533-4406</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1912035</identifier><identifier>PMID: 32160663</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adult ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Aspirin ; Aspirin - administration &amp; dosage ; Aspirin - adverse effects ; Bleeding ; Carcinoma, Hepatocellular - mortality ; Chronic infection ; Drug dosages ; Emigration ; Female ; Gastrointestinal Hemorrhage - chemically induced ; Hepatitis ; Hepatitis B ; Hepatitis B, Chronic - complications ; Hepatitis C ; Hepatitis C, Chronic - complications ; Hepatocellular carcinoma ; Humans ; Infections ; Liver cancer ; Liver diseases ; Liver Neoplasms - mortality ; Long-term effects ; Male ; Middle Aged ; Mortality ; Patients ; Prescriptions ; Prevention ; Registries ; Risk ; Sweden - epidemiology</subject><ispartof>The New England journal of medicine, 2020-03, Vol.382 (11), p.1018-1028</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2020 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-da970b7fffee4ea5ad0c9fe3caf70f73b488bdf271eefba9c79d4b79becbfb73</citedby><cites>FETCH-LOGICAL-c564t-da970b7fffee4ea5ad0c9fe3caf70f73b488bdf271eefba9c79d4b79becbfb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1912035$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa1912035$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,550,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32160663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-81583$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:144199358$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Simon, Tracey G</creatorcontrib><creatorcontrib>Duberg, Ann-Sofi</creatorcontrib><creatorcontrib>Aleman, Soo</creatorcontrib><creatorcontrib>Chung, Raymond T</creatorcontrib><creatorcontrib>Chan, Andrew T</creatorcontrib><creatorcontrib>Ludvigsson, Jonas F</creatorcontrib><title>Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than among nonusers.</description><subject>Adult</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Aspirin</subject><subject>Aspirin - administration &amp; dosage</subject><subject>Aspirin - adverse effects</subject><subject>Bleeding</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Chronic infection</subject><subject>Drug dosages</subject><subject>Emigration</subject><subject>Female</subject><subject>Gastrointestinal Hemorrhage - chemically induced</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B, Chronic - complications</subject><subject>Hepatitis C</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Infections</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Liver Neoplasms - mortality</subject><subject>Long-term effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Prescriptions</subject><subject>Prevention</subject><subject>Registries</subject><subject>Risk</subject><subject>Sweden - epidemiology</subject><issn>0028-4793</issn><issn>1533-4406</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>D8T</sourceid><recordid>eNp1kU1v1DAQhi0EokvhyBVFQtwI-Cuxc0FaLaUFbQGhiqtlO-PWSxIvttOq_75GuxT20JGsGdnPvGP7Reglwe8Ibtr3X0--nAdNOkIxax6hBWkYqznH7WO0wJjKmouOHaFnKW1wCcK7p-iIUdLitmUL9H2ZUrBeZx-mKrhqmbY--qm68fmqOoOtzsHCMMyDjtVKR-unMOpKT3219tcQ6x8w6Ax9dR5i1oPPt8_RE6eHBC_2-RhdfDq5WJ3V62-nn1fLdW2blue6153ARjjnADjoRvfYdg6Y1U5gJ5jhUpreUUEAnNGdFV3PjegMWOOMYMeo3smmG9jORm2jH3W8VUF7td_6VSpQXFBJaeHfPsh_9D-XKsTLsmYlSSNZwT_s8MKO0FuYctTDQdfhyeSv1GW4VoIR0XJZBF7vBWL4PUPKahPmOJUfUZSJlkouCf_3ChtDShHc_QSC1R971YG9hX_1_7Xu6b9-FuDNDhjHpCbYjA8I3QHyx7BK</recordid><startdate>20200312</startdate><enddate>20200312</enddate><creator>Simon, Tracey G</creator><creator>Duberg, Ann-Sofi</creator><creator>Aleman, Soo</creator><creator>Chung, Raymond T</creator><creator>Chan, Andrew T</creator><creator>Ludvigsson, Jonas F</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D91</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20200312</creationdate><title>Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality</title><author>Simon, Tracey G ; Duberg, Ann-Sofi ; Aleman, Soo ; Chung, Raymond T ; Chan, Andrew T ; Ludvigsson, Jonas F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-da970b7fffee4ea5ad0c9fe3caf70f73b488bdf271eefba9c79d4b79becbfb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Aspirin</topic><topic>Aspirin - administration &amp; dosage</topic><topic>Aspirin - adverse effects</topic><topic>Bleeding</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Chronic infection</topic><topic>Drug dosages</topic><topic>Emigration</topic><topic>Female</topic><topic>Gastrointestinal Hemorrhage - chemically induced</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B, Chronic - complications</topic><topic>Hepatitis C</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Infections</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Liver Neoplasms - mortality</topic><topic>Long-term effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Prescriptions</topic><topic>Prevention</topic><topic>Registries</topic><topic>Risk</topic><topic>Sweden - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simon, Tracey G</creatorcontrib><creatorcontrib>Duberg, Ann-Sofi</creatorcontrib><creatorcontrib>Aleman, Soo</creatorcontrib><creatorcontrib>Chung, Raymond T</creatorcontrib><creatorcontrib>Chan, Andrew T</creatorcontrib><creatorcontrib>Ludvigsson, Jonas F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Örebro universitet</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simon, Tracey G</au><au>Duberg, Ann-Sofi</au><au>Aleman, Soo</au><au>Chung, Raymond T</au><au>Chan, Andrew T</au><au>Ludvigsson, Jonas F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2020-03-12</date><risdate>2020</risdate><volume>382</volume><issue>11</issue><spage>1018</spage><epage>1028</epage><pages>1018-1028</pages><issn>0028-4793</issn><issn>1533-4406</issn><eissn>1533-4406</eissn><abstract>This registry study examined the association between aspirin use and hepatocellular carcinoma and liver-related mortality in adults in Sweden with hepatitis B or hepatitis C. The 10-year cumulative incidences of hepatocellular carcinoma and liver-related death were lower among aspirin users than among nonusers.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>32160663</pmid><doi>10.1056/NEJMoa1912035</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2020-03, Vol.382 (11), p.1018-1028
issn 0028-4793
1533-4406
1533-4406
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_472822
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online; New England Journal of Medicine
subjects Adult
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Aspirin
Aspirin - administration & dosage
Aspirin - adverse effects
Bleeding
Carcinoma, Hepatocellular - mortality
Chronic infection
Drug dosages
Emigration
Female
Gastrointestinal Hemorrhage - chemically induced
Hepatitis
Hepatitis B
Hepatitis B, Chronic - complications
Hepatitis C
Hepatitis C, Chronic - complications
Hepatocellular carcinoma
Humans
Infections
Liver cancer
Liver diseases
Liver Neoplasms - mortality
Long-term effects
Male
Middle Aged
Mortality
Patients
Prescriptions
Prevention
Registries
Risk
Sweden - epidemiology
title Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A48%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Aspirin%20with%20Hepatocellular%20Carcinoma%20and%20Liver-Related%20Mortality&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Simon,%20Tracey%20G&rft.date=2020-03-12&rft.volume=382&rft.issue=11&rft.spage=1018&rft.epage=1028&rft.pages=1018-1028&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa1912035&rft_dat=%3Cproquest_swepu%3E2376284814%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2376284814&rft_id=info:pmid/32160663&rfr_iscdi=true